Plozasiran Notches Big Wins in Severe Hypertriglyceridemia
(MedPage Today) -- Treatment with plozasiran (Redemplo) significantly reduced triglycerides among patients with severe hypertriglyceridemia, two phase III studies showed. Compared with placebo, the small interfering RNA therapy reduced triglycerides...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.